Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial

Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for adjuvant de-escalated radiation and nivolumab in p16-positive oropharyngeal cancer is now displayed, including eligibility, treatment details, outcomes, and study results. The record identifies the trial as completed and no longer recruiting participants.
    Difference
    85%
    Check dated 2026-11-07T15:06:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:50:28.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:13:30.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:20:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T20:32:44.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This means the NCT03715946 study details are no longer accessible on the page.
    Difference
    24%
    Check dated 2026-09-19T20:18:20.000Z thumbnail image

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.